Similarly, ubiquitin-like modifier activating enzyme 1 (UBA1), which has been reported to participate in the development of HCC by modulating cell phenotypes and ferroptosis via the NRF2 pathway, is proposed to be a promising diagnostic and prognostic indicator for HCC (Shan et al., 2020). This evidence concerns the gene UBA1 and hepatocellular carcinoma.